Related Experiment Video

Updated: Jul 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Novel therapies targeting signaling pathways in lung cancer

Adam Yagui-Beltrán1, Biao He, Dan Raz

  • 1Department of Surgery, University of California San Francisco Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA 94143-0128, USA.

Thoracic Surgery Clinics
|January 24, 2007
PubMed

Insights

Targeting molecular pathways in non-small cell lung cancer (NSCLC) offers new therapeutic strategies. Understanding embryonic signaling pathways like Hedgehog, Notch, and Wnt can lead to more specific and effective lung cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Advanced non-small-cell lung cancer (NSCLC) has a poor prognosis despite chemotherapy.
  • Molecular understanding of lung carcinogenesis is driving new targeted therapies.

Purpose of the Study:

  • To examine molecular events in lung cancer development.
  • To explore how this knowledge informs new therapeutic agent development.
  • To investigate embryonic signaling pathways for novel lung cancer treatments.

Main Methods:

  • Review of molecular events in lung cancer.
  • Analysis of targeted therapeutic strategies.
  • Exploration of embryonic signaling pathways (Hedgehog, Notch, Wnt) in tumorogenesis.

Main Results:

  • Molecular insights are guiding the development of novel lung cancer agents.
  • Targeted therapies can be used alone or with chemotherapy.
  • Embryonic pathways are crucial targets for future lung cancer therapies.

Conclusions:

  • Targeting molecular pathways is key to improving NSCLC outcomes.
  • Embryonic signaling pathways offer promising avenues for developing specific lung cancer therapies.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...